Implant Sciences Corporation (OTCQB: IMSC) has shipped approximately USD1 million of its QS-B220 desktop explosives and drugs trace detectors and its QS-H150 handheld explosives trace detectors over the past year, the company said.
A large portion of the sales, which were previously unannounced, were shipped to fulfill additional demand for aviation security in European nations. Over the past year, Implant Sciences has been selected by high profile airports across 14 EU nations and has deployed over 1,000 units to support ECAC regulations.
Implant Sciences develops and manufactures advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The company´s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the US, ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior.